Toggle navigation
Home
Search
Services
Blog
Contact
About
Mechanisms of Steroid Reduction in Ivig Treated Asthma
Gelfand, Erwin William
National Jewish Health, Denver, CO, United States
Search 61 grants from Erwin Gelfand
Search grants from National Jewish Health
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
The Role of Osteopontin in Cancer Progression and Bone Metastasis
Mapping of Electron Tunneling Pathway in Proteins
Immune regulation of the B7-H1 pathway
Chemical Models of Presynaptic Neuromuscular Diseases
Design for Impact - Creating Effective Student Activities that Faculty Will Use
Recently added grants:
Ca2+ and ROS Crosstalk Signaling in Cardiac Mitochondria
Hypertension in Adult IUGR Offspring: Beneficial Effects of Perinatal Intervention
An adolescent sensitive period for thalamo-prefrontal circuit maturation
TTC39B in Metabolism
Antibacterial Resistance Leadership Group (ARLG)
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Small Research Grants (R03)
Project #
1R03AI041022-01
Application #
2005571
Study Section
Special Emphasis Panel (ZAI1-SRC (99))
Project Start
1996-08-01
Project End
1998-06-30
Budget Start
1996-08-01
Budget End
1997-07-31
Support Year
1
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
National Jewish Health
Department
Type
DUNS #
City
Denver
State
CO
Country
United States
Zip Code
80206
Related projects
NIH 1997
R03 AI
Mechanisms of Steroid Reduction in Ivig Treated Asthma
Gelfand, Erwin William / National Jewish Health
NIH 1996
R03 AI
Mechanisms of Steroid Reduction in Ivig Treated Asthma
Gelfand, Erwin William / National Jewish Health
Publications
Spahn, J D; Leung, D Y; Chan, M T et al.
(1999)
Mechanisms of glucocorticoid reduction in asthmatic subjects treated with intravenous immunoglobulin.
J Allergy Clin Immunol 103:421-6
Comments
Be the first to comment on Erwin Gelfand's grant